Research ReportOxymatrine protects rat brains against permanent focal ischemia and downregulates NF-κB expression
Introduction
Ischemic stroke remains a leading cause of death and disability worldwide. In acute stroke, neuron apoptosis and inflammation play an important role in tissue loss and neurological deficit. Oxymatrine (OMT) is the major quinolizidine alkaloid from the root of Sophora flavescens Ait (kushen). The structure of OMT is clear as shown in Fig. 1. It has been proved that OMT has anti-inflammatory, anti-apoptosis, anti-tumor, anti-viral and anti-arrhythmic effects. OMT also exerts a protective effect on ischemia or ischemia/reperfusion damage in liver, intestine and heart (Jiang et al., 2005, Zhao et al., 2008, Hong-Li et al., 2008). In the colitis induced by dextran sulfate sodium, OMT ameliorates the colonic inflammation through reducing expression of NF-κB in colonic mucosa (Zheng et al., 2005).
Nuclear factor-kappa B (NF-κB) is a ubiquitously expressed transcription factor that regulates expression of genes involved in inflammation, cell survival and apoptosis (Małek et al., 2007). There are many evidences that NF-κB is upregulated following ischemia (Terai et al., 1996, Gabriel et al., 1999). Also many data suggest that inhibition of NF-κB reduces infarction volume and develops less ischemic damage in permanent ischemia especially; maybe NF-κB antagonists are therapeutic agents for stroke (Shen et al., 2003, Schneider et al., 1999, Ueno et al., 2001, Xu et al., 2002, Nurmi et al., 2004a, Nurmi et al., 2004b).
The aim of this study was to investigate whether OMT has a neuroprotective effect in the rat model of permanent middle cerebral artery occlusion (pMCAO) and the potential mechanisms for its neuroprotection.
Section snippets
OMT treatment and neurological deficit after pMCAO in rats
Neurological deficit was examined and scored on a 6-point scale and Mann–Whitney U test analysis was conducted. Neurological deficit scores were significantly decreased by OMT at a dose of 120 mg/kg (P < 0.05) versus saline-treated pMCAO group. At a dose of 60 mg/kg, OMT reduced the scores, but did not reach a significance level (Fig. 2).
Effect of OMT on infarct volume in pMCAO rats
No infarction was observed in sham operated group, Fig. 3 displayed the image of the untreated and treated animals at 72 h after cerebral ischemia. In pMCAO
Discussion
Our study provided evidence that OMT was a potent neuroprotectants in brain ischemia. Here, our study showed that administration of 120 mg/kg OMT was sufficient to provide significant neuroprotection against neurological injury induced by pMCAO. We supported this finding by both histological and neurological data: a reduction in the brain infarct volume and an attenuation of the neurological deficit, both of which are clinical features and related with the quality of life after stroke. Also the
Animals
Male Sprague–Dawley rats, weighing 260 to 280 g were provided by Hebei Medical University. The protocol was approved by the institutional animal care and use committee and the local experimental ethics committee. Rats were kept under a 12/12 h light/dark cycle and given free access to food and water. The animals were randomly divided into 4 groups (n = 15 for each group): pMCAO group, high dose group (animals with pMCAO and 120 mg/kg OMT treatment), low dose group (animals with pMCAO and 60 mg/kg
Acknowledgments
This work was funded by Hebei Province, No.:C2006000915; we thank technician Ruichun Liu and Hongran Wu for their technical assistance and Dr. Yi Yang, Dr. Litao Li, Dr. Jing Yin and Dr. Yansu Guo for providing valuable suggestions.
References (25)
- et al.
Global cerebral ischemia activates nuclear factor-kappa B prior to evidence of DNA fragmentation
Brain Res. Mol. Brain Res.
(1997) - et al.
NF-kappaB protects neurons from ischemic injury after middle cerebral artery occlusion in mice
Brain Res.
(2006) - et al.
Activation of nuclear factor-kappaB in the rat brain after transient focal ischemia
Brain Res. Mol. Brain Res.
(1999) - et al.
The NF-kappa B inhibitor diethyldithiocarbamate (DDTC) increases brain cell death in a transient middle cerebral artery occlusion model of ischemia
Brain Res. Bull.
(2001) - et al.
Activation of NF-κB and ERK1/2 after permanent focal ischemia is abolished by simvastatin treatment
Neurobiol. Dis.
(2006) - et al.
Enhancement of immunoreactivity for NF-κB in human cerebral infarctions
Brain Res.
(1996) - et al.
Nuclear factor-kappa B decoy attenuates neuronal damage after global brain ischemia: a future strategy for brain protection during circulatory arrest
J. Thorac. Cardiovasc. Surg.
(2001) - et al.
Recombinant adenoviral expression of dominant negative IkappaBalpha protects brain from cerebral ischemic injury
Biochem. Biophys. Res. Commun.
(2002) - et al.
Role of transcription factors in mediating post-ischemic cerebral inflammation and brain damage
Neurochem. Int.
(2007) - et al.
Drug-induced neuroprotection from global ischemia is associated with prevention of persistent but not transient activation of nuclear factor-kappa B in rats
Stroke
(1998)